These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 34289832)

  • 41. miR-29a-3p suppresses hepatic fibrosis pathogenesis by modulating hepatic stellate cell proliferation via targeting PIK3R3 gene expression.
    Fu J; Wu B; Zhong S; Deng W; Lin F
    Biochem Biophys Res Commun; 2020 Sep; 529(4):922-929. PubMed ID: 32819600
    [TBL] [Abstract][Full Text] [Related]  

  • 42. miRNA-576-5p promotes endometrial cancer cell growth and metastasis by targeting ZBTB4.
    Chen C; Zhang Q; Kong B
    Clin Transl Oncol; 2023 Mar; 25(3):706-720. PubMed ID: 36538280
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduced miR-29a-3p expression is linked to the cell proliferation and cell migration in gastric cancer.
    Zhao Z; Wang L; Song W; Cui H; Chen G; Qiao F; Hu J; Zhou R; Fan H
    World J Surg Oncol; 2015 Mar; 13():101. PubMed ID: 25889078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated Expression of miR302-367 in Endothelial Cells Inhibits Developmental Angiogenesis via CDC42/CCND1 Mediated Signaling Pathways.
    Pi J; Liu J; Zhuang T; Zhang L; Sun H; Chen X; Zhao Q; Kuang Y; Peng S; Zhou X; Yu Z; Tao T; Tomlinson B; Chan P; Tian Y; Fan H; Liu Z; Zheng X; Morrisey E; Zhang Y
    Theranostics; 2018; 8(6):1511-1526. PubMed ID: 29556338
    [No Abstract]   [Full Text] [Related]  

  • 46. Overexpression of miR-222-3p Promotes the Proliferation and Inhibits the Apoptosis of Diffuse Large B-Cell Lymphoma Cells via Suppressing PPP2R2A.
    Sun S; Wang H; Ji M
    Technol Cancer Res Treat; 2019; 18():1533033819892256. PubMed ID: 31829105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. miR-29a-3p mitigates the development of osteosarcoma through modulating IGF1 mediated PI3k/Akt/FOXO3 pathway by activating autophagy.
    Qi S; Xu L; Han Y; Chen H; Cheng A
    Cell Cycle; 2022 Sep; 21(18):1980-1995. PubMed ID: 35575588
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
    Wang JR; Liu B; Zhou L; Huang YX
    Cancer Biomark; 2019; 24(2):159-172. PubMed ID: 30614803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Upregulation of long non-coding RNA OGFRP1 facilitates endometrial cancer by regulating miR-124-3p/SIRT1 axis and by activating PI3K/AKT/GSK-3β pathway.
    Lv Y; Chen S; Wu J; Lin R; Zhou L; Chen G; Chen H; Ke Y
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2083-2090. PubMed ID: 31131636
    [TBL] [Abstract][Full Text] [Related]  

  • 50. COL4A1, negatively regulated by XPD and miR-29a-3p, promotes cell proliferation, migration, invasion and epithelial-mesenchymal transition in liver cancer cells.
    Zhang H; Wang Y; Ding H
    Clin Transl Oncol; 2021 Oct; 23(10):2078-2089. PubMed ID: 33891266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PTTG1 regulated by miR-146a-3p promotes bladder cancer migration, invasion, metastasis and growth.
    Xiang W; Wu X; Huang C; Wang M; Zhao X; Luo G; Li Y; Jiang G; Xiao X; Zeng F
    Oncotarget; 2017 Jan; 8(1):664-678. PubMed ID: 27893422
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miR-1 Inhibits Cell Growth, Migration, and Invasion by Targeting VEGFA in Osteosarcoma Cells.
    Niu J; Sun Y; Guo Q; Niu D; Liu B
    Dis Markers; 2016; 2016():7068986. PubMed ID: 27777493
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LncRNA BLACAT1 Promotes Proliferation, Migration and Invasion of Prostate Cancer Cells via Regulating miR-29a-3p/DVL3 Axis.
    Liao B; Chen S; Li Y; Yang Z; Yang Y; Deng X; Ke S
    Technol Cancer Res Treat; 2021; 20():1533033820972342. PubMed ID: 33641528
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
    Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
    Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
    IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LncRNA AFAP1-AS1 contributes to the progression of endometrial carcinoma by regulating miR-545-3p/VEGFA pathway.
    Zhong Y; Wang Y; Dang H; Wu X
    Mol Cell Probes; 2020 Oct; 53():101606. PubMed ID: 32504788
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Knockdown of TUG1 by shRNA inhibited renal cell carcinoma formation by miR-299-3p/VEGF axis in vitro and in vivo.
    Li Y; Zheng D; Pan L; Dai Y; Cai S; Zhao L; Zhu H
    Eur J Pharmacol; 2019 Oct; 860():172536. PubMed ID: 31310753
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α.
    Han N; Xu H; Yu N; Wu Y; Yu L
    Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):85-94. PubMed ID: 31408201
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LncRNA RHPN1-AS1 promoted cell proliferation, invasion and migration in cervical cancer via the modulation of miR-299-3p/FGF2 axis.
    Duan H; Li X; Chen Y; Wang Y; Li Z
    Life Sci; 2019 Dec; 239():116856. PubMed ID: 31525429
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overexpression of p21-activated kinase 1 promotes endometrial cancer progression.
    Lu W; Qu JJ; Li BL; Lu C; Yan Q; Wu XM; Chen XY; Wan XP
    Oncol Rep; 2013 Apr; 29(4):1547-55. PubMed ID: 23338047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.